Editas Medicine, Inc.

EDIT · XNAS

CIK 1650664fmd_19WA5W3NV6RTGVAN2KT75Y70TMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.